retatrutide clinical trial results 2025 Lilly orforglipron oral GLP-1 phase 3 weight loss New Phase 3 retatrutide data

However, stopping the medication also means losing the appetite suppression and weight loss benefits

Brain activation in response to low-calorie food pictures: an explorative analysis of a randomized trial with dapagliflozin and exenatide

Retatrutide is an investigational once-weekly triple agonist that targets GLP-1, GIP, and glucagon receptors

Short courses are fine but chronic use defeats part of the mechanism

This is exactly why Clean Eatz Kitchen existsand why our meals are perfectly suited for people on GLP-1 medications

Studies show that GLP-1RAs enhance insulin production, motility, and sperm metabolism, all of which can result in improved sperm parameters